ArticleBMJ global health2025
Community-based mobile tuberculosis clinics in rural Madagascar: impact and cost-effectiveness analysis.
Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Precision geospatial targeting for cost-effective tuberculosis case finding in Eastern Uganda: a quasi-experimental study.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTuberculosis (TB) remains an important public health challenge globally. Madagascar faces a substantial TB burden despite enhanced efforts from its national TB control programme. This necessitates innovative and context-specific TB prevention and care interventions that are both impactful and cost-effective. We evaluated the effectiveness and cost-effectiveness of a community-based mobile TB clinic intervention in a remote rural area of Madagascar, addressing specific access barriers and implementation challenges.
methodsThe analysis employed an interrupted time series analysis (ITSA) comparing the intervention to the standard national TB control programme (NTP) to assess the effectiveness of the intervention in increasing TB case detection rates. A decision tree model was used to evaluate the cost-effectiveness of the intervention from a healthcare provider perspective when compared with the NTP. The study incorporated one-way sensitivity analyses and Monte Carlo simulations with 10 000 iterations to generate the probability distribution of estimates and uncertainty ranges.
resultsThe ITSA found that the intervention cumulatively increased TB case detection 2.88-fold compared with the control group over the 27-month study period. The probability for a patient to successfully complete TB treatment in the intervention group was 97%, compared with 91% in the control group. Incremental costs per person with TB were $316. With an incremental cost-effectiveness ratio (ICER) of $25 per disability-adjusted life year averted, well below the $96 cost effectiveness threshold for Madagascar, the intervention was highly cost-effective. Importantly, the ICER remained robust throughout sensitivity analyses, reaching a maximum of $67.
conclusionThe study underscores the importance of community-based interventions for TB and calls for policymakers to prioritise and scale up such interventions, both in Madagascar and in other low-income countries with similar access-related challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.